15 research outputs found
Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine
In respect to the heterogeneity among influenza A virus strains and the shortcomings of current vaccination programs, there is a huge interest in the development of alternative vaccines that provide a broader and more long-lasting protection. Gene-based approaches are considered as promising candidates for such flu vaccines. In our study, innate signalling molecules from the RIG-I and the NALP3 pathways were evaluated as genetic adjuvants in intramuscular DNA immunizations. Plasmids encoding a constitutive active form of RIG-I (cRIG-I), IPS-1, IL-1β, or IL-18 were co-administered with plasmids encoding the hemagglutinin and nucleoprotein derived from H1N1/Puerto Rico/8/1934 via electroporation in BALB/c mice. Immunogenicity was analysed in detail and efficacy was demonstrated in homologous and heterologous influenza challenge experiments. Although the biological activities of the adjuvants have been confirmed by in vitro reporter assays, their single or combined inclusion in the vaccine did not result in superior vaccine efficacy. With the exception of significantly increased levels of antigen-specific IgG1 after the co-administration of IL-1β, there were only minor alterations concerning the immunogenicity. Since DNA electroporation alone induced substantial inflammation at the injection site, as demonstrated in this study using Mx2-Luc reporter mice, it might override the adjuvants´ contribution to the inflammatory microenvironment and thereby minimizes the influence on the immunogenicity. Taken together, the DNA immunization was protective against subsequent challenge infections but could not be further improved by the genetic adjuvants analysed in this study
Evidence for Type Ia Supernova Diversity from Ultraviolet Observations with the Hubble Space Telescope
We present ultraviolet (UV) spectroscopy and photometry of four Type Ia
supernovae (SNe 2004dt, 2004ef, 2005M, and 2005cf) obtained with the UV prism
of the Advanced Camera for Surveys on the Hubble Space Telescope. This dataset
provides unique spectral time series down to 2000 Angstrom. Significant
diversity is seen in the near maximum-light spectra (~ 2000--3500 Angstrom) for
this small sample. The corresponding photometric data, together with archival
data from Swift Ultraviolet/Optical Telescope observations, provide further
evidence of increased dispersion in the UV emission with respect to the
optical. The peak luminosities measured in uvw1/F250W are found to correlate
with the B-band light-curve shape parameter dm15(B), but with much larger
scatter relative to the correlation in the broad-band B band (e.g., ~0.4 mag
versus ~0.2 mag for those with 0.8 < dm15 < 1.7 mag). SN 2004dt is found as an
outlier of this correlation (at > 3 sigma), being brighter than normal SNe Ia
such as SN 2005cf by ~0.9 mag and ~2.0 mag in the uvw1/F250W and uvm2/F220W
filters, respectively. We show that different progenitor metallicity or
line-expansion velocities alone cannot explain such a large discrepancy.
Viewing-angle effects, such as due to an asymmetric explosion, may have a
significant influence on the flux emitted in the UV region. Detailed modeling
is needed to disentangle and quantify the above effects.Comment: 17 pages, 13 figures, accepted by Ap
Evaluation of IL-1 and IL-18 as genetic adjuvants in adenoviral immunizations against influenza A viruses
Aktuelle Influenza A Virus (IAV) Impfungen induzieren eine Stamm-spezifische Immunität und sind nur gegen die im Impfstoff enthaltenen Stämme wirksam. Schutz gegen veränderte IAV oder neue Subtypen wird nicht erzeugt. In dieser Arbeit wurde ein Impfstoff-Ansatz verfolgt, der einen möglichst breiten Schutz gegen alle IAV Stämme gewährleistet. Dazu wurden Mäuse intranasal mit adenoviralen Vektoren kodierend für Hämagglutinin und Nucleoprotein immunisiert. Das interne virale Protein Nukleoprotein ist zwischen allen IAV Stämmen konserviert und ein optimales Ziel für eine breit-schützende T Zell-Antwort. Darüber hinaus wurden Vektoren kodierend für IL-1 oder IL-18 in den Impfstoff integriert, um die T Zell-Antwort zu verbessern. IL-1- aber nicht IL-18-kodierende Vektoren verbesserten sowohl die humorale als auch die T Zell-Antwort. Insbesondere lokale CD8 T Zellen in der Lunge wurden vermehrt induziert und führten zu einem verbesserten Schutz gegen heterologe H1N1, H3N2 und H7N7 Stämme
Naturally occurring variants in the transmembrane and cytoplasmic domains of the human Coxsackie- and adenovirus receptor have no impact on virus internalisation.
Herrmann L, Filip A, Lapuente D, et al. Naturally occurring variants in the transmembrane and cytoplasmic domains of the human Coxsackie- and adenovirus receptor have no impact on virus internalisation. Biochemical and biophysical research communications. 2020.The Coxsackie- and adenovirus receptor (CAR) mediates homophilic cell-cell contacts and susceptibility to both human pathogenic viruses through its membrane-distal immunoglobulin domain. In the present study, we screened five missense variants of the human CAR gene for their influence on adenovector or Coxsackievirus entry into Chinese hamster ovary cells. The CAR variants facilitated virus internalisation to a similar extent as wild type CAR. This underlines CAR's presumed invariance and essential physiological role in embryogenesis. Copyright © 2020 Elsevier Inc. All rights reserved
Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNA
The importance of a balanced TH1/TH2 humoral immune response against the HIV-1 envelope protein (Env) for antibody-mediated HIV-1 control is increasingly recognized. However, there is no defined vaccination strategy to raise it. Since immune checkpoints are involved in the induction of adoptive immunity and their inhibitors (monoclonal antibodies) are licensed for cancer therapy, we investigated the effect of checkpoint blockade after HIV-1 genetic vaccination on enhancement and modulation of antiviral antibody responses. By intraperitoneal administration of checkpoint antibodies in mice we observed an induction of anti-drug antibodies which may interfere with immunomodulation by checkpoint inhibitors. Therefore, we blocked immune checkpoints locally by co-electroporation of DNA vaccines encoding the active soluble ectodomains of programmed cell death protein-1 (PD-1) or its ligand (PD-L1), respectively. Plasmid-encoded immune checkpoints did not elicit a detectable antibody response, suggesting no interference with their immunomodulatory effects. Co-electroporation of a HIV-1 DNA vaccine formulation with soluble PD-L1 ectodomain increased HIV-1 Env-specific TH1 CD4 T cell and IgG2a antibody responses. The overall antibody response was hereby shifted towards a more TH1/TH2 balanced subtype pattern. These findings indicate that co-electroporation of soluble checkpoint ectodomains together with DNA-based vaccines has modulatory effects on vaccine-induced immune responses that could improve vaccine efficacies
Genetic Co-Administration of Soluble PD-1 Ectodomains Modifies Immune Responses against Influenza A Virus Induced by DNA Vaccination
Due to the low efficacy and the need for seasonal adaptation of currently licensed influenza A vaccines, the importance of alternative vaccination strategies is increasingly recognized. Considering that DNA vaccines can be rapidly manufactured and readily adapted with novel antigen sequences, genetic vaccination is a promising immunization platform. However, the applicability of different genetic adjuvants to this approach still represents a complex challenge. Immune checkpoints are a class of molecules involved in adaptive immune responses and germinal center reactions. In this study, we immunized mice by intramuscular electroporation with a DNA-vaccine encoding hemagglutinin (HA) and nucleoprotein (NP) of the influenza A virus. The DNA-vaccine was applied either alone or in combination with genetic adjuvants encoding the soluble ectodomains of programmed cell death protein-1 (sPD-1) or its ligand (sPD-L1). Co-administration of genetic checkpoint adjuvants did not significantly alter immune responses against NP. In contrast, sPD-1 co-electroporation elevated HA-specific CD4+ T cell responses, decreased regulatory CD4+ T cell pools, and modulated the IgG2a-biased HA antibody pattern towards an isotype-balanced IgG response with a trend to higher influenza neutralization in vitro. Taken together, our data demonstrate that a genetic DNA-adjuvant encoding soluble ectodomains of sPD-1 was able to modulate immune responses induced by a co-administered influenza DNA vaccine
Alcohol-sourced acetate impairs T cell function by promoting cortactin acetylation
Summary: Alcohol is among the most widely consumed dietary substances. Excessive alcohol consumption damages the liver, heart, and brain. Alcohol also has strong immunoregulatory properties. Here, we report how alcohol impairs T cell function via acetylation of cortactin, a protein that binds filamentous actin and facilitates branching. Upon alcohol consumption, acetate, the metabolite of alcohol, accumulates in lymphoid organs. T cells exposed to acetate, exhibit increased acetylation of cortactin. Acetylation of cortactin inhibits filamentous actin binding and hence reduces T cell migration, immune synapse formation and activation. While mutated, acetylation-resistant cortactin rescues the acetate-induced inhibition of T cell migration, primary mouse cortactin knockout T cells exhibited impaired migration. Acetate-induced cytoskeletal changes effectively inhibited activation, proliferation, and immune synapse formation in T cells in vitro and in vivo in an influenza infection model in mice. Together these findings reveal cortactin as a possible target for mitigation of T cell driven autoimmune diseases
MOESM1 of Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors
Additional file 1: Figure S1. Experimental layout. CB6F1 mice were immunized with 25 µg plasmid DNA each encoding Leader-Gag, Leader-Gag and Env, or Leader-Gag, Env and a cytokine. Antibody and CD8+ T cell responses were analysed two weeks after immunization. Three weeks after immunization, mice were challenged with 5000 SFFU FV, and plasma and spleen viral loads were analysed ten days and 21 days after FV infection, respectively
MOESM2 of Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors
Additional file 2: Figure S2. Immunization with cytokine-encoding vectors alone. CB6F1 mice were immunized once with DNA plasmids encoding cytokines as indicated; 25 µg of plasmid were injected intramuscularly followed by in vivo electroporation. Three weeks after immunization, mice were infected with 5000 spleen focus forming units FV. The development of splenomegaly was monitored by palpation of the spleen twice a week (A). Three weeks after FV challenge, mice were sacrificed and spleen weight (B) and viral loads in spleen cells were determined (C). Data were acquired in one experiment. The bars in (A) indicate the mean values, whiskers indicate the standard error of the means. Each dot (B, C) indicates an individual mouse, bars indicate mean (B) or median (C) values. The grey-bordered dots above the grey lines (B, C) indicate mice that were sacrificed before the end of the experiment due to severe disease development; they were not included in data analysis. Data were analysed by Kruskall-Wallis One Way Analysis of Variance on Ranks and Dunn’s multiple comparison procedure; n.s. = not significant compared to unvaccinated mice (P > 0.05)
Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
The envelope protein (Env) is the only surface protein of the human immunodeficiency virus (HIV) and as such the exclusive target for protective antibody responses. Experimental evidences from mouse models suggest a modulating property of Env to steer antibody class switching towards the less effective antibody subclass IgG1 accompanied with strong TH2 helper responses. By simple physical linkage we were able to imprint this bias, exemplified by a low IgG2a/IgG1 ratio of antigen-specific antibodies, onto an unrelated antigen, namely the HIV capsid protein p24. Here, our results indicate the glycan moiety of Env as the responsible immune modulating activity. Firstly, in Card9−/− mice lacking specific C-Type lectin responsiveness, DNA immunization significantly increased the IgG2a/IgG1 ratio for the Env-specific antibodies while the antibody response against the F-protein of the respiratory syncytial virus (RSV) serving as control antigen remained unchanged. Secondly, sequential shortening of the Env encoding sequence revealed the C2V3 domain as responsible for the strong IgG1 responses and TH2 cytokine production. Removing all potential N-glycosylation sites from the C2V3 domain by site-specific mutagenesis reversed the vaccine-induced immune response towards a Th1-dominated T-cell response and a balanced IgG2a/IgG1 ratio. Accordingly, the stretch of oligomannose glycans in the C2V3 domain of Env might mediate a specific uptake and/or signaling modus in antigen presenting cells by involving interaction with an as yet unknown C-type lectin receptor. Our results contribute to a deeper understanding of the impact of Env glycosylation on HIV antigen-specific immune responses, which will further support HIV vaccine development